Arcturus Therapeutics
ARCT
ARCT
147 hedge funds and large institutions have $453M invested in Arcturus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 31 closing their positions.
Holders
147
Holders Change
-17
Holders Change %
-10.37%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
55
Reduced
47
Closed
31
Calls
$2.94M
Puts
$2.98M
Net Calls
-$39K
Net Calls Change
-$1.7M
Top Buyers
1 |
1
Balyasny Asset Management
Chicago,
Illinois
|
$9.31M |
2 |
SSA
2
Schonfeld Strategic Advisors
New York
|
$14.4M |
3 |
JGC
3
J. Goldman & Co
New York
|
$5.02M |
4 |
4
Morgan Stanley
New York
|
$9.14M |
5 |
MB
5
MPM BioImpact
Boston,
Massachusetts
|
$7.81M |